Tirzepatide functions as a dual GIP and GLP-1 receptor agonist, which means it targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Cardiovascular outcome benefits have been established primarily in people with type 2 diabetes for certain GLP-1 receptor agonists, with evidence in non-diabetic populations still emerging
In laboratory studies, survodutide shows an EC50 of approximately 8 nM for the glucagon receptor and 1 nM for the GLP-1 receptor
Third-Party Testing: Trusted brands will have their products tested by outside labs to verify that the potency matches the label and that the product is free from contaminants
Berning P, Adhikari R, Schroer AE, Jelwan YA, Razavi AC, Blaha MJ, et al
By combining these two powerful ingredients, L Pace offers a unique synergistic effect, providing a comprehensive approach to supporting energy levels, endurance, and overall vitality